section name header

Table 86-2

Recommended Treatment for Gonococcal Infections: Adapted from the 2015 Guidelines of the Centers for Disease Control and Prevention

DIAGNOSISTREATMENT OF CHOICEa
Uncomplicated gonococcal infection of the cervix, urethra, pharynxb , or rectum
First-line regimen

Ceftriaxone (250 mg IM, single dose)

plus

Azithromycin (1 g PO, single dose)

Alternative regimensc

Cefixime (400 mg PO, single dose) or ceftizoxime (500 mg IM, single dose) or cefotaxime (500 mg IM, single dose) or spectinomycin (2 g IM, single dose)d,e or cefotetan (1 g IM, single dose) plus probenecid (1 g PO, single dose)d or cefoxitin (2 g IM, single dose) plus probenecid (1 g PO, single dose)d

plus

Azithromycin (1 g PO, single dose)

EpididymitisCeftriaxone (250 mg IM once) followed by doxycycline (100 mg PO bid for 10 days)
Pelvic inflammatory diseaseSee text on specific syndrome
Gonococcal conjunctivitis in an adultCeftriaxone (1 g IM, single dose)f
Ophthalmia neonatorumg Ceftriaxone (25-50 mg/kg IV, single dose, not to exceed 125 mg)
Disseminated gonococcal infectionh
Initial therapyi
Pt tolerant of β-lactam drugsCeftriaxone (1 g IM or IV q24h; recommended) or cefotaxime (1 g IV q8h) or ceftizoxime (1 g IV q8h)
Pts allergic to β-lactam drugsSpectinomycin (2 g IM q12h)d
Continuation therapyiCefixime (400 mg PO bid)
Meningitis or endocarditisSee text for specific recommendationsj

a True failure of treatment with a recommended regimen is rare and should prompt an evaluation for reinfection, infection with a drug-resistant strain, or an alternative diagnosis.

b Ceftriaxone and azithromycin are the only agents recommended for treatment of pharyngeal infection.

c See text for follow-up of persons with infection who are treated with alternative regimens.

d Spectinomycin, cefotetan, and cefoxitin, which are alternative agents, currently are unavailable or in short supply in the United States.

e Spectinomycin may be ineffective for the treatment of pharyngeal gonorrhea.

f Plus lavage of the infected eye with saline solution (once).

g Prophylactic regimens are discussed in the text.

h Hospitalization is indicated if the diagnosis is uncertain, if the pt has frank arthritis with an effusion, or if the pt cannot be relied on to adhere to treatment.

i All initial regimens should also include azithromycin (1 g PO, single dose) and should be continued for 24-48 h after clinical improvement begins, at which time the switch may be made to an oral agent (e.g., cefixime) if antimicrobial susceptibility can be documented by culture of the causative organism. If no organism is isolated and the diagnosis is secure, then treatment with ceftriaxone should be continued for at least 1 week.

j Hospitalization is indicated to exclude suspected meningitis or endocarditis.